Document:

Exhibit

	
			
	NOMAD FOODS LIMITED

	 
	LONG TERM 2015 INCENTIVE PLAN
ISSUE [  ]
RESTRICTED SHARE UNIT AGREEMENT
	 

THIS AGREEMENT is made the [   ] day of [    ], 20[  ] 
		
	(1)
	Nomad Foods Limited, a public company limited by shares and incorporated under the laws of the British Virgin Islands (the "Company"); and

		
	(2)
	[Participant name], ("you").

WHEREAS:-
		
	(A)
	The Company has adopted the Nomad Foods Limited Long Term 2015 Incentive Plan (as changed from time to time and as modified for UK Eligible Persons by the UK Sub-Plan) (the “Plan”) for the benefit of employees and directors of the Company and Group Companies; and

		
	(B)
	The Committee has authorised the Award to you of Restricted Share Units under the Plan, on the terms and conditions set out in the Plan and this Agreement (as may be amended or supplemented from time to time).

IT IS AGREED:-
		
	1.
	INTERPRETATION

		
	1.1
	Terns defined in the rules of the Plan (but not defined in this Agreement) have the same meaning in this Agreement as in the rules of the Plan, unless the context requires otherwise, and except as set out below:

	
			
	“Award Shares”
	has the meaning given to that term in Clause 2.1;
	 

	“Performance Conditions”
	means the performance conditions set out in Schedule 1 to this Agreement;

	“Performance Period”
	;
	 

	"Vesting Date"
	means <date>
	 

		
	1.2
	The rules of interpretation in the Plan also apply to this Agreement.

		
	2. 
	GRANT OF AWARD

		
	2.1
	Subject to the other terms of this Agreement and the rules of the Plan (which are incorporated into the Agreement by reference), the Company hereby grants to you an Award in the form of Restricted Share Units over [number] ordinary shares in the Company (the “Award Shares”). 

		
	2.2
	By accepting the Award, you confirm your commitment to remain employed by a Group Company at least until such time as the Award Vests.

		
	2.3
	The Award is made effective as of <date>

		
	3.
	VESTING AND LAPSE OF AWARD

		
	3.1
	The Award will Vest only in accordance with the rules of the Plan and the terms of this Agreement. 

		
	3.2
	The Award will Vest on the Vesting Date only if, and to the extent that, the Performance Conditions are satisfied and subject to the employment condition outlined in Schedule 1

		
	3.3
	The Award will not Vest until the Vesting Date except where earlier Vesting is permitted by Rule 9 or Rule 10 of the Plan. In the event that the Award Vests under Rule 10.1 or Rule 10.2 of the Plan, the Committee will have the option to scale back the Award to reflect the period between the start of the Performance Period and the date of the Change of Control as a proportion of the Performance Period as a whole.

		
	3.4
	In the event that (i) a Change of Control occurs, (ii) the Award does not Vest as a result of the Change of Control under Rule 10.1 or Rule 10.2 of the Plan, and (iii) your office or employment with a Group Company is terminated by a Group Company, or you are given notice of the termination of your office or employment with a Group Company, within 183 days following the Change of Control (except in circumstances where termination is for Misconduct), then, unless, the Committee determines otherwise, you will be considered to be a Good Leaver, and the provisions of Rule 9.1 will apply to the Award.  

		
	3.5
	The Award may lapse if certain events occur, in accordance with the rules of the Plan.

		
	4.
	SHARE ISSUANCE AND CERTIFICATES

		
	4.1
	As and when the Restricted Share Units Vest under to this Agreement and the Plan, the Company will issue and allot (or, as appropriate, transfer or procure the transfer of) the Award Shares which have Vested to you as soon as administratively practicable after such Vesting and in any event no later than 30 days thereafter. 

		
	5.
	TERMS OF AWARD

		
	5.1
	The Award is subject to the rules of the Plan (which are incorporated by reference in the Agreement).

		
	5.2
	The rules of the Plan take precedence over any conflicting statement about the terms of the Award in this Agreement. 

		
	5.3
	You will have no right to vote and no right to any dividends with respect to the Award Shares subject to this Award until and only to the extent that the Award Vests in accordance with Clause 3.

		
	5.4
	This Agreement, the Award and the Award Shares awarded under this Agreement are subject to such rules and regulations as the Committee may adopt pursuant to the Plan. All decisions of the Committee upon any question arising under the Plan or under this Agreement shall be final, conclusive and binding upon you and any other person claiming any interest in the Award.

		
	5.5
	The terms of this Award of Restricted Share Units as evidenced by this Agreement may be amended by the Committee without your approval, subject however to the limitations set out in the Plan or may be amended by written agreement between you and the Company. The Company reserves the right to amend the Plan at any time, subject to any limitations set out in the Plan.

		
	6. 
	WITHHOLDING

		
	6.1
	You agree that you are responsible for paying any Tax and Social Security Liability arising in connection with the Award, and that the Company and any Group Company are entitled to deduct and withhold from any payment of any kind otherwise due to you the minimum amount necessary to satisfy their withholding obligations in respect of any such Tax and Social Security Liability. 

		
	6.2
	To enable the Company and any Group Company to discharge its or their withholding obligations, you irrevocably agree to authorize any Group Company to withhold from the Award Shares that would otherwise Vest or be deliverable to you the number of Award Shares that have a market value, as of the date the Tax and Social Security Liability arises, less than or equal to the amount of the Tax and Social Security Liability.

		
	6.2
	The Tax Liability in Clause 6.1 does not include employer Social Security contributions.

		
	7.
	CLAWBACK

		
	7.1
	You irrevocably agree that the provisions of Schedule 2 to this Agreement apply to the Award. 

		
	8.
	MISCELLANEOUS

		
	8.1
	You acknowledge and irrevocably agree that your rights and obligations under the terms of your office or employment with the Company or any Group Company are not affected by the grant of the Award. The grant of the Award does not confer on you any right with respect to continuance of employment by the Company or any Group Company, nor does it interfere in any way with the right of the Company to terminate your employment at any time. The grant of the Award to you does not entitle you to any further grants of Awards on any future occasion. You have no rights to compensation or damages in consequence of the termination of your office or employment with the Company or any Group Company for any reason whatsoever, whether or not in breach of contract, insofar as those rights arise or may arise from the loss or diminution in value of the Award or the Award Shares.

		
	8.2
	No waiver at any time of any term or provision of this Agreement shall be construed as a waiver of any other term or provision of this Agreement and a waiver at any time of any term or provision of this Agreement shall not be construed as a waiver at any subsequent time of the same term or provision.

		
	8.2
	All headings set forth in this Agreement are intended for convenience only and do not control or affect the meaning, construction or effect of this Agreement or of any of the provisions hereof.

		
	8.3
	This Agreement may be executed in any number of counterparts, each of which when executed and delivered shall constitute a duplicate original, but all the counterparts shall together constitute the one agreement. Transmission of an executed counterpart of this agreement (but for the avoidance of doubt not just a signature page) by (a) fax or (b) email (in PDF, JPEG or other agreed format) shall take effect as delivery of an executed counterpart of this agreement. If either method of delivery is adopted, without prejudice to the validity of the agreement thus made, each party shall provide the others with the original of such counterpart as soon as reasonably possible thereafter.  No counterpart shall be effective until each party has executed and delivered at least one counterpart.

		
	8.4
	A person who is not a party to this Agreement shall have no right under the Contracts (Rights of Third Parties) Act 1999 to enforce any of its terms.  

		
	8.5
	 This Agreement and any disputes or claims arising out of or in connection with it or its subject matter or formation (including non-contractual disputes or claims) shall be governed by and construed in accordance with the law of England and Wales. You and the Company agree that the courts of England and Wales shall have exclusive jurisdiction to settle any dispute or claim arising out of or in connection with this agreement or its subject matter or formation (including non-contractual disputes and claims). 

In witness whereof the parties hereto have executed this Agreement on
day of             

Company                    Participant
By: _______________________________    By: _______________________________

Its   _______________________________

SCHEDULE 1

PERFORMANCE CONDITIONS

The Vesting of the Award is subject to the satisfaction of the Performance Conditions set out in this Schedule 1 as of the Vesting Date.  

The Performance Conditions are made up of two elements:
		
	•
	A condition relating to certain financial measures of performance, which are measured over the period of three years from <date> to <date>, and which are set out in Section 1 below (the “Performance Measures”), and

		
	•
	A condition relating to continued employment, which is measured over the period up to the Vesting Date, <date>, as set out in Section 2 below (the “Continued Employment Condition”). 

For the purpose of determining the Performance Measures, the Award is divided into three tranches, each with its own performance test. These are:
		
	•
	The EBITDA Tranche,

		
	•
	The Net Sales Tranche, and

		
	•
	The Share Price Tranche. 

Each Tranche will only Vest (a) if, and to the extent that, the Performance Measure applying to that Tranche as set out in Section 1 below has been satisfied and (b) if the Continued Employment Condition has been satisfied. 

		
	1.
	PERFORMANCE MEASURES

1.1    EBITDA Tranche

The EBITDA Tranche is comprised of one third of the total number of Award Shares specified in Clause 2.1 of the Agreement (the “EBITDA Shares”). The performance test which applies to the EBITDA Tranche relates to cumulative adjusted EBITDA between <date> and <date> (the “EBITDA Test”). As soon as reasonably practicable after <date> the Company’s cumulative adjusted EBITDA for the period <date> and <date> will be determined by the Committee.  The percentage of EBITDA Shares which will Vest (subject to the Continued Employment Condition) shall be determined based on Cumulative Adjusted EBITDA for the period <date> and <date>, in accordance with the following table: 

	
		
	Cumulative Adjusted EBITDA for the period <date> to <date>
	Percentage of EBITDA Shares that will Vest

	Less than EUR xxx mio
	x%

	At least EUR xxx mio, but less than EUR xxx mio
	x%

	EUR xxx mio
	x%

	More than EUR xxx mio, but less than EUR xxx mio
	x%

	EUR xxx mio or more
	x%

In addition, the following will apply to the EBITDA Tranche:

		
	(i)
	the EBITDA Test must be achieved, if at all, as at <date> and, therefore, cannot be achieved before that date; 

		
	(ii)
	in assessing whether the EBITDA Test has been achieved, the Committee may use such accounting methods, assumptions, guidance and principles as it in its reasonable discretion sees fit; 

		
	(iii)
	the EBITDA Test may be adjusted by the Committee to reflect any acquisitions or divestitures by the Company after the date of this Agreement (based on business case assumptions minus synergies in years x-x); and

		
	(iv)
	“cumulative adjusted EBITDA” may be adjusted and calculated in a way which is consistent with how the Company reports (or plans to report) to the public and should there be a change in the way the Company so reports, EBITDA will be adjusted equitably to reflect the changes.

1.2    Net Sales Tranche

The Net Sales Tranche is comprised of one third of the total number of Award Shares specified in Clause 2.1 of the Agreement (the “Net Sales Shares”).  The performance test which applies to the Net Sales Tranche relates to cumulative Net Sales between <date> and <date> (the “Net Sales Test”). As soon as reasonably practicable after <date> the Company’s cumulative Net Sales for the period <date> and <date> will be determined by the Committee.  The percentage of Net Sales Shares which will Vest (subject to the Continued Employment Condition) shall be determined based on Cumulative Net Sales for the period <date> and <date>, in accordance with the following table:
	
		
	Cumulative Net Sales for the period <date> to <date>
	Percentage of Net Sales Shares that will Vest

	Less than EUR xxx mio
	x%

	At least EUR xxx mio, but less than EUR xxx mio
	x%

	EUR xxx mio
	x%

	More than EUR xxx mio, but less than EUR xxx mio
	Increasing on a straight- line basis between x% and x%

	EUR xxx mio or more
	x%

1.3    Share Price Tranche

The Share Price Tranche is comprised of one third of the total number of Award Shares specified in Clause 2.1 of the Agreement (the “Share Price Shares”). The performance test which applies to the Share Price Tranche relates to the Company’s share price performance between <date> and <date> (the “Share Price Test”). The percentage of Share Price Shares that will Vest (subject to the Continued Employment Condition) will be based on the VWAP of the ordinary shares of the Company reaching one of the Share Price Thresholds specified in the table below for a continuous period of x trading days between <date> and <date>, on in accordance with the following table:

	
		
	Share Price Vesting Threshold
	Percentage of Share Price Shares that will vest

	Less than $x
	x%

	$x

	x%

	$x

	x%

	$x

	x%

For this purpose:
		
	1.
	The “Share Price Vesting Threshold” is the level of the VWAP of the ordinary shares of the Company on the New York Stock Exchange (or such other exchange on which the Company maintains its principal listing) which must be exceeded for a continuous period of at least x trading days during the Measurement Period in order for the specified percentage of Third Tranche Award Shares to Vest.

		
	2.
	“VWAP” means, as of any date or relevant period, as applicable, the volume weighted average price for an ordinary share of the Company on the New York Stock Exchange (or such other exchange on which the Company maintains its principal listing) as reported by Bloomberg through its “Volume at Price” function (or such other data reporting service as may be determined by the Committee in its sole discretion); provided however, if the ordinary shares of the Company do not trade on any exchange, the VWAP will be the last closing trade price of an ordinary share of the Company in the over-the-counter market on the electronic bulletin board for that security as reported by Bloomberg (and if no last closing trade price is reported for an ordinary share of the Company by Bloomberg, the last closing ask price of an ordinary share of the Company as reported by Bloomberg). If the VWAP cannot be calculated for an ordinary share of the Company on that date on any of the foregoing bases, the VWAP of an ordinary share of the Company on such date will be the fair market value as determined by the Committee. 

1.4    Adjustments to the Performance Measures

If an event occurs which, in the reasonable opinion of the Committee, means that a Performance Measure is no longer appropriate, the Committee may vary or waive that Performance Measure, provided that the varied Performance Measure is (in the reasonable opinion of the Committee) a fairer measure of performance than the original Performance Measure, as judged at the time of the variation, and no more difficult to satisfy than the original Performance Measure was at the Grant Date. 

2.    CONTINUED EMPLOYMENT CONDITION

		
	2.1
	The relevant portion Award that would vest based on the Performance Measures will Vest only if you are a director or employee of a Group Company on the Vesting Date and are not then under notice of termination of office or employment (whether given by you, your employer or any other Group Company), unless the Committee determines in its absolute discretion to allow the Award to Vest notwithstanding that you are no longer a director or employee of a Group 

Company on the Vesting Date or that notice has been given (but, in each case, subject always to the satisfaction of the relevant Performance Measures).

		
	2.2
	The Award will lapse if you voluntarily cease to be a director or employee of a Group Company between <date> and the Vesting Date, unless the Company’s Chief Executive Officer and Human Resources Director (or the Committee in the case of Board Members) determine in their absolute discretion to allow the Award to continue to exist and to Vest on the Vesting Date (subject always to the satisfaction of the relevant Performance Measures). 

SCHEDULE 2

CLAWBACK

		
	1.
	CIRCUMSTANCES IN WHICH CLAWBACK CAN APPLY

		
	1.1
	This Schedule 2 applies in relation to the Award if:

		
	(a)
	either or both of paragraphs 1.2 and/or 1.3 apply; and

		
	(b)
	paragraph 1.4 applies.

		
	1.2
	This paragraph 1.2 applies in relation to an Award if the Committee, at its discretion, determines that any of the following circumstances exist:

		
	(a)
	you have participated in or were responsible for conduct which resulted in significant losses to a Group Company;

		
	(b)
	you have failed to meet appropriate standards of fitness and propriety;

		
	(c)
	the Company has reasonable evidence of fraud or material dishonesty by you; 

		
	(d)
	the Company has become aware of any material wrongdoing on your part;

		
	(e)
	you have has acted in any manner which in the opinion of the Committee has brought or is likely to bring any Group Company into material disrepute or is materially adverse to the interests of any Group Company;

		
	(f)
	there is a breach of your employment contract that is a potentially fair reason for dismissal;

		
	(g)
	you are in breach of a fiduciary duty owed to any Group Company or any client or customer of any Group Company; 

		
	(h)
	you whether alone or with others entice or otherwise encourage a team or group of Employees to move to another firm;

		
	(i)
	you have ceased to be an employee but were in breach of your employment contract or fiduciary duties in a manner that would have prevented the grant or Vesting of the Award had the Company been aware (or fully aware) of that breach, and which the Company was not aware (or not fully aware) until after:

(i)    both:
		
	(aa)
	you ceased to be an employee; and

		
	(bb)
	the time Award Vested; or

(ii)    there was a material error in:
		
	(aa)
	 determining whether the Award should be granted; or

		
	(bb) 
	determining the size and nature of the Award.

		
	1.3
	This paragraph 1.3 applies in relation to an Award if the Committee, at its discretion, determines that either of the following circumstances exist:

		
	(a)
	 a Group Company mis-stated any financial information (whether audited or not) for any part of any financial year that was taken into account in:

		
	(i)
	determining whether the Award should be made; or

		
	(ii)
	determining the size and nature of the Award; or 

		
	(b)
	a Group Company or business unit that employs or employed you, or for which you are responsible, has suffered a material failure of risk management.

		
	1.4
	This paragraph 1.4 applies in relation to an Award if the Committee, at its discretion, determines that, if the circumstances mentioned in paragraphs 1.2 or 1.3 had existed, and the Committee had been fully aware that they existed at the date on which the Award was granted, then:

		
	(a)
	the Committee would not have granted the Award; or

		
	(b)
	the Committee would have granted the Award in relation to a smaller number of Restricted Share Units.

		
	1.5
	 If the Committee makes a determination in relation to an Award under this paragraph 1, it must do so within three years of the Vesting Date. 

		
	2.
	OPERATION OF CLAWBACK

		
	2.1
	This paragraph 2 applies to an Award if paragraph 1 applies to the Award.

		
	2.2
	If at the end of the determination under paragraph 1.4, the Award has Vested, the Committee may determine a Clawback Amount in relation to the Award.

		
	2.3
	The Clawback Amount shall be such amount as the Committee considers to be fair and reasonable, taking account of all circumstances that the Committee considers to be relevant.

		
	2.4
	If you have paid or are liable to pay any amount of a Tax and Social Security Liability which cannot be recovered from or repaid by any relevant tax authority (whether directly or indirectly), the Committee may in its discretion decide to, or where paragraph 1.3 applies, will, reduce the Clawback Amount to take account of this amount. In deciding whether to reduce the Clawback Amount, the Committee shall take account of such factors as it thinks fit, which may include market practice, corporate governance rules and guidelines, and the expectations of shareholders.

		
	2.5
	For the avoidance of doubt, the Committee is not obliged to determine a Clawback Amount in relation to any particular Award, even if the Committee does determine a Clawback Amount in relation to other Awards to the same or other holders of Awards which were granted or which Vested on the same date or dates. 

		
	2.6
	You shall reimburse the Company for the Clawback Amount, in any way acceptable to the Committee, on or as soon as possible after the Committee determines a Clawback Amount in relation to the Award. If you fail to reimburse the Company within 30 days after the determination, the Company shall obtain reimbursement from you in any (or a combination) of the following ways:

		
	(a)
	by reducing or cancelling any cash bonus payable to you by any Group Company;

		
	(b)
	by reducing or cancelling any future or existing award made or option granted to you under any other share incentive plan or bonus plan operated by any Group Company (other than a Schedule 2 SIP or a Schedule 3 SAYE option plan, as those terms are defined in ITEPA);

		
	(c)
	by requiring you to make a cash payment to a Group Company; or

		
	(d)
	by reducing your salary.

		
	2.7
	If you participate in another share incentive plan or bonus plan operated by a Group Company, and that other plan contains a provision that has a similar effect to paragraph 1, the Committee may give effect to that provision by causing the Award to lapse for no consideration in respect of such number of Award Shares (up to the total number of Award Shares) as the Committee considers to be fair and reasonable.Exhibit

Exhibit 4.1

DESCRIPTION OF CAPITAL STOCK
For a more detailed description of capital stock, you should refer to the provisions of our restated certificate of incorporation and our amended and restated bylaws, each of which is incorporated by reference as an exhibit to this Form 10-K, as well as the applicable provisions of the General Corporation Law of the State of Delaware (the “DGCL”).
Description of the Registrant’s Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Arcosa, Inc. has registered its common stock, par value $0.01 per share, under Section 12 of the Securities Exchange Act of 1934. In this discussion, the terms “Arcosa,” “we,” “us” and “our” refer only to Arcosa, Inc. and not to any of its subsidiaries. 
Authorized Capital Stock
Our authorized capital stock consists of (i) 200,000,000 shares of common stock, par value $0.01 per share; and (ii) 20,000,000 shares of preferred stock, par value $0.01 per share.
Common Stock
Each holder of Arcosa common stock is entitled to one vote for each share on all matters to be voted upon by the common stockholders. The holders of Arcosa common stock are not entitled to cumulative voting of their shares. Subject to any preferential rights of any outstanding preferred stock, holders of Arcosa common stock are entitled to receive ratably the dividends, if any, as may be declared from time to time by Arcosa’s board of directors (the “Board of Directors”) out of funds legally available for that purpose. If there is a liquidation, dissolution, or winding up of Arcosa, holders of its common stock would be entitled to ratable distribution of its assets remaining after the payment in full of liabilities and any preferential rights of any outstanding preferred stock. 
Holders of Arcosa common stock have no preemptive or conversion rights or other subscription rights, and there are no redemption or sinking fund provisions applicable to the common stock. The rights, preferences, and privileges of the holders of Arcosa common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that Arcosa may designate and issue in the future.
Preferred Stock
Under the terms of our restated certificate of incorporation, the Board of Directors is authorized to issue shares of preferred stock in one or more series without further action by the holders of our common stock. The Board of Directors has the discretion, subject to limitations prescribed by Delaware law and by our restated certificate of incorporation, to determine the rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, terms of redemption, and liquidation preferences, of each series of preferred stock.
Our Board of Directors could authorize Arcosa to issue a class or series of preferred stock that could, depending upon the terms of the particular class or series, delay, defer, or prevent a transaction or a change of control of our Company, even if such transaction or change of control involves a premium price for our stockholders or our stockholders believe that such transaction or change of control may be in their best interests. The Board of Directors may be able to issue preferred stock with voting rights or conversion rights that, if exercised, could adversely affect the voting power of the holders of common stock.
Anti-Takeover Effects of Various Provisions of Delaware Law and our Certificate of Incorporation and Bylaws
Provisions of the DGCL, our restated certificate of incorporation and amended and restated bylaws could make it more difficult to acquire Arcosa by means of a tender offer, a proxy contest or otherwise or to remove incumbent officers and directors. These provisions are expected to discourage certain types of coercive takeover practices and takeover bids that our Board of Directors may consider inadequate and to encourage persons seeking to acquire control of the Company to first negotiate with our Board of Directors. We believe that the benefits of increased protection of our ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure it outweigh the 

disadvantages of discouraging takeover or acquisition proposals because, among other things, negotiation of these proposals could result in an improvement of their terms. Such provisions, among other things, include:
		
	•
	Section 203 of the DGCL, an anti-takeover statute prohibits a publicly held Delaware corporation from engaging in a “business combination” with an “interested stockholder” for a period of three years following the time the person became an interested stockholder, unless the business combination or the acquisition of shares that resulted in a stockholder becoming an interested stockholder is approved in a prescribed manner (generally, a “business combination” includes a merger, asset or stock sale or other transaction resulting in a financial benefit to the interested stockholder. Generally, an “interested stockholder” is a person who, together with affiliates and associates, owns (or within three years prior to the determination of interested stockholder status did own) 15 percent or more of a corporation’s voting stock);

		
	•
	a classified board with three approximately equal classes of directors until the 2022 annual meeting of shareholders, at which time each director will stand for election annually;

		
	•
	no removal of directors without cause while the Board of Directors is classified;

		
	•
	amendment of the bylaws by the Board of Directors or by the affirmative vote of holders of at least a majority of the outstanding capital stock entitled to vote thereon;

		
	•
	the number of directors on the Board of Directors may not be less than five nor more than eleven, with the exact number of directors to be fixed exclusively by the Board of Directors and any vacancies created in the Board of Directors resulting from any increase in the authorized number of directors will be filled by a majority of the Board of Directors then in office; 

		
	•
	stockholders may not call special stockholder meetings and only the Board of Directors, the Chairperson of the Board of Directors or the President may call special meetings of Arcosa stockholders;

		
	•
	action must take place at the annual or a special meeting of Arcosa stockholders and stockholders have no right to act by written consent; 

		
	•
	advance notice procedures with respect to stockholder proposals and nomination of candidates for election as directors (other than nominations made by or at the direction of the Board of Directors);

		
	•
	ability to issue additional shares of common stock or preferred stock without stockholder approval, subject to applicable rules of the NYSE, or a comparable public market, and Delaware law, for a variety of corporate purposes; and

		
	•
	no cumulative voting.

Transfer Agent and Registrar
The transfer agent and registrar for the shares of common stock is American Stock Transfer & Trust Company. The transfer agent and registrar’s address is 6201 15th Avenue, Brooklyn, NY 11219. 
Stock Exchange Listing
Our common stock is listed on the NYSE under the symbol “ACA”.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00305-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00305-of-00352.parquet"}]]